Drug recommend to pregnant

Drug recommended to pregnant patients with previous preterm deliveries: 17 alpha hydroxyprogesterone caproate (17P):

The American College of Obstetricians and Gynecologists(ACOG) issued a press release regarding the use of progesterone as treatment for help preventing preterm deliveries . The purpose of the press release was to recommend that all pregnant women with a prior history of preterm birth (before 37 weeks of gestation), be treated with weekly injections of 17 P. This recommendation was based on two studies done using progesterone in a selected group of high risk patients who had a previous preterm delivery. One of these studies used intramuscular injections of 17 alpha hydroxyprogesterone caproate beginning at 16-20 of pregnancy through 36 weeks or until delivery. This regimen showed a significant benefit in patients that received the medication, who had up to 42 percent fewer preterm deliveries than women that did not received the medication (those who received placebo).

At VITA Healthcare we provide the service of weekly 17P injections in the home or work place for patients at risk. If you want more information please click on the following link:


The FDA appoved the use of 17-hydroxyprogesterone (17-P) for the prevention of preterm delivery in patients with a prior preterm delivery. The use of 17P for this indication has been recommended by the Americal College of Obstetrics and Gynecology since 2008.

PR highest rate of preterm birth in the nation

Puerto Rico has an estimated preterm birth rate of nearly 20 percent. For the United States this rate is approximately 13 percent. March of Dimes issued a State by State Report Card on pretem births on November 2008 and Puerto Rico got an “F”, having the highest rate of preterm birth in the nation. The best grade was obtained by the state of Vermont, who got a “B”, for 9 percent of preterm deliveries. This grades were based on data from the CDC from 2005, the most recent year for which final birth trends data is available. Preliminary data for 2006 show a slight increase in the nation’s preterm bith rate from 12.7% in 2005 to 12.8% in 2006. As you can see this is a serious problem that affects significantly our population. In VITA Healthcare we offer services which main purpose is try to help decrease the preterm labor by using medications and uterine contraction monitors that can be used as outpatient therapies for patients with preterm labor.